Literature DB >> 21479929

Immunological alterations mediated by adenosine during host-microbial interactions.

Ioannis Drygiannakis1, Peter B Ernst, David Lowe, Ian J Glomski.   

Abstract

Adenosine accumulates in inflammation and ischemia but it is more than an end-product of ATP catabolism. Signaling through different receptors with distinct, cell-specific cytoplasmic pathways, adenosine is now recognized as an inducible switch that regulates the immune system. By acting through the A(2A)AR, adenosine shapes T cell function, largely by conferring an anti-inflammatory tone on effector Th cells (Teff) and natural killer (NK)T cells. In contrast, both the A(2A)AR and A(2B)AR are expressed by antigen-presenting cells (APC) which have been shown to regulate innate responses and the transition to adaptive immunity. There is also emerging evidence that adenosine production is one mechanism that allows some pathogens as well as neoplasms to evade host defenses. This review discusses the immunoregulatory functions of adenosine and some of the interactions it may have in regulating host-microbial interactions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21479929      PMCID: PMC3361322          DOI: 10.1007/s12026-011-8207-0

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  95 in total

1.  A2A adenosine receptor protects tumors from antitumor T cells.

Authors:  Akio Ohta; Elieser Gorelik; Simon J Prasad; Franca Ronchese; Dmitriy Lukashev; Michael K K Wong; Xiaojun Huang; Sheila Caldwell; Kebin Liu; Patrick Smith; Jiang-Fan Chen; Edwin K Jackson; Sergey Apasov; Scott Abrams; Michail Sitkovsky
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-17       Impact factor: 11.205

2.  New insights into the regulation of inflammation by adenosine.

Authors:  Joel Linden
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

Review 3.  The translation of Helicobacter pylori basic research to patient care.

Authors:  Peter B Ernst; David A Peura; Sheila E Crowe
Journal:  Gastroenterology       Date:  2006-01       Impact factor: 22.682

4.  HIF-dependent induction of adenosine A2B receptor in hypoxia.

Authors:  Tianqing Kong; Karen A Westerman; Marion Faigle; Holger K Eltzschig; Sean P Colgan
Journal:  FASEB J       Date:  2006-11       Impact factor: 5.191

5.  CD73 is expressed by human regulatory T helper cells and suppresses proinflammatory cytokine production and Helicobacter felis-induced gastritis in mice.

Authors:  Mohammad S Alam; Courtney C Kurtz; Robert M Rowlett; Brian K Reuter; Elizabeth Wiznerowicz; Soumita Das; Joel Linden; Sheila E Crowe; Peter B Ernst
Journal:  J Infect Dis       Date:  2009-02-15       Impact factor: 5.226

6.  HIF-dependent induction of adenosine receptor A2b skews human dendritic cells to a Th2-stimulating phenotype under hypoxia.

Authors:  Meixiang Yang; Chunhong Ma; Shuxun Liu; Qianqian Shao; Wenjuan Gao; Bingfeng Song; Jintang Sun; Qi Xie; Yun Zhang; Alei Feng; Yanguo Liu; Weixu Hu; Xun Qu
Journal:  Immunol Cell Biol       Date:  2009-10-20       Impact factor: 5.126

7.  Isolated CD39 expression on CD4+ T cells denotes both regulatory and memory populations.

Authors:  Q Zhou; J Yan; P Putheti; Y Wu; X Sun; V Toxavidis; J Tigges; N Kassam; K Enjyoji; S C Robson; T B Strom; W Gao
Journal:  Am J Transplant       Date:  2009-07-28       Impact factor: 8.086

8.  The A2B adenosine receptor impairs the maturation and immunogenicity of dendritic cells.

Authors:  Jeffrey M Wilson; William G Ross; Oma N Agbai; Renea Frazier; Robert A Figler; Jayson Rieger; Joel Linden; Peter B Ernst
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

9.  Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model.

Authors:  S E Gabriel; K N Brigman; B H Koller; R C Boucher; M J Stutts
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728

10.  From "Hellstrom Paradox" to anti-adenosinergic cancer immunotherapy.

Authors:  Dmitriy Lukashev; Michail Sitkovsky; Akio Ohta
Journal:  Purinergic Signal       Date:  2007-01-24       Impact factor: 3.765

View more
  11 in total

Review 1.  Adenosine signaling and adenosine deaminase regulation of immune responses: impact on the immunopathogenesis of HIV infection.

Authors:  Daniela F Passos; Viviane M Bernardes; Jean L G da Silva; Maria R C Schetinger; Daniela Bitencourt Rosa Leal
Journal:  Purinergic Signal       Date:  2018-08-10       Impact factor: 3.765

Review 2.  Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly.

Authors:  Tobias R Kollmann; Ofer Levy; Ruth R Montgomery; Stanislas Goriely
Journal:  Immunity       Date:  2012-11-16       Impact factor: 31.745

3.  Infectious diseases are analogous with cancer. Hypothesis and implications.

Authors:  Daniel Benharroch; Lidia Osyntsov
Journal:  J Cancer       Date:  2012-03-06       Impact factor: 4.207

4.  Release of Periplasmic Nucleotidase Induced by Human Antimicrobial Peptide in E. coli Causes Accumulation of the Immunomodulator Adenosine.

Authors:  Andreia Bergamo Estrela; Patrick Türck; Elaine Stutz; Wolf-Rainer Abraham
Journal:  PLoS One       Date:  2015-09-15       Impact factor: 3.240

5.  Ecto-5'-nucleotidase (CD73) regulates host inflammatory responses and exacerbates murine salmonellosis.

Authors:  M Samiul Alam; Jennifer L Kuo; Peter B Ernst; Victoria Derr-Castillo; Marion Pereira; Dennis Gaines; Matthew Costales; Elmer Bigley; Kristina Williams
Journal:  Sci Rep       Date:  2014-03-27       Impact factor: 4.379

Review 6.  Purinergic signalling and immune cells.

Authors:  Geoffrey Burnstock; Jean-Marie Boeynaems
Journal:  Purinergic Signal       Date:  2014-10-29       Impact factor: 3.765

Review 7.  Unfolding Role of a Danger Molecule Adenosine Signaling in Modulation of Microbial Infection and Host Cell Response.

Authors:  Jaden S Lee; Özlem Yilmaz
Journal:  Int J Mol Sci       Date:  2018-01-09       Impact factor: 5.923

Review 8.  The Adenosine Pathway and Human Immunodeficiency Virus-Associated Inflammation.

Authors:  Emily A Hixson; Priya V Borker; Edwin K Jackson; Bernard J Macatangay
Journal:  Open Forum Infect Dis       Date:  2021-07-24       Impact factor: 3.835

Review 9.  Immune heterogeneity in neuroinflammation: dendritic cells in the brain.

Authors:  Carol A Colton
Journal:  J Neuroimmune Pharmacol       Date:  2012-11-01       Impact factor: 4.147

10.  Deconstructing the traditional Japanese medicine "Kampo": compounds, metabolites and pharmacological profile of maoto, a remedy for flu-like symptoms.

Authors:  Akinori Nishi; Katsuya Ohbuchi; Hirotaka Kushida; Takashi Matsumoto; Keiko Lee; Haruo Kuroki; Shigeki Nabeshima; Chika Shimobori; Nagisa Komokata; Hitomi Kanno; Naoko Tsuchiya; Makoto Zushi; Tomohisa Hattori; Masahiro Yamamoto; Yoshio Kase; Yukiko Matsuoka; Hiroaki Kitano
Journal:  NPJ Syst Biol Appl       Date:  2017-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.